Compounds > celecoxib

celecoxib and carbostyril

celecoxib has been researched along with carbostyril in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (16.67)29.6817
2010's9 (75.00)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Kimoto, A; Miyata, K; Noguchi, M; Okutsu, H; Sasamata, M; Yoshino, T1
Byun, Y; Choi, Y; Kim, SY; Lee, C; Park, K; Yang, JH1
Ishihara, T; Mizushima, T; Tanaka, K; Tashiro, S; Yoshida, K1
Hasegawa, M; Horiki, N; Katsurahara, M; Sudo, A; Takei, Y; Tanaka, K; Tano, S; Uchida, A; Wakabayashi, H1
Cho, ML; Jeong, JH; Kim, EK; Kim, HY; Min, JK; Moon, SJ; Park, JS; Park, MK; Park, SH; Yang, EJ1
Cooper, DL; Harirforoosh, S; Wood, RC; Wyatt, JE1
Bullins, KW; Denham, JW; Hanley, AV; Hanley, GA; Harirforoosh, S; Panus, PC; Wood, RC; Wyatt, JE1
Conney, AH; Cui, XX; Ding, N; Du, Z; Gao, Z; Hu, C; Huang, H; Lin, Y; Rabson, AB; Shih, WJ; Wei, X; Zheng, X1
Das, SK; Dash, R; Fisher, PB; Maji, S; Panda, S; Pattanaik, L; Pellecchia, M; Quinn, BA; Samal, SK; Sarkar, D1
Denham, JW; Harirforoosh, S; Murrell, DE; Panus, PC; Rahmasari, Y1
Chaurasia, M; Chowdhury, T; Das, S; Dey, KK; Mandal, M; Pal, I; Parida, S; Rajesh, Y; Sharma, K1
Chen, J; Goodin, S; Li, DL; Ma, YR; Ma, YY; Ren, X; Wang, X; Xu, XT; Zhang, K; Zhao, DG; Zheng, X; Zhou, RP1

Trials

1 trial(s) available for celecoxib and carbostyril

ArticleYear
The efficacy of rebamipide add-on therapy in arthritic patients with COX-2 selective inhibitor-related gastrointestinal events: a prospective, randomized, open-label blinded-endpoint pilot study by the GLORIA study group.
    Modern rheumatology, 2013, Volume: 23, Issue:6

    Topics: Alanine; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastrointestinal Diseases; Humans; Low Back Pain; Male; Middle Aged; Osteoarthritis; Pilot Projects; Pyrazoles; Quinolones; Sulfonamides; Treatment Outcome; Upper Gastrointestinal Tract

2013

Other Studies

11 other study(ies) available for celecoxib and carbostyril

ArticleYear
Celecoxib does not induce convulsions nor does it affect GABAA receptor binding activity in the presence of new quinolones in mice.
    European journal of pharmacology, 2005, Jan-10, Volume: 507, Issue:1-3

    Topics: Animals; Celecoxib; Male; Mice; Protein Binding; Pyrazoles; Quinolones; Receptors, GABA-A; Seizures; Sulfonamides

2005
Chemoprevention of 4-NQO-induced oral carcinogenesis by co-administration of all-trans retinoic acid loaded microspheres and celecoxib.
    Journal of controlled release : official journal of the Controlled Release Society, 2005, May-05, Volume: 104, Issue:1

    Topics: 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Celecoxib; Cyclooxygenase Inhibitors; Delayed-Action Preparations; Drug Therapy, Combination; Female; Liposomes; Male; Pyrazoles; Quinolones; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Sulfonamides; Tongue Neoplasms; Tretinoin

2005
Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis.
    Biochemical pharmacology, 2010, Jun-01, Volume: 79, Issue:11

    Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Apoptosis; Calcium Channels; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Gastric Mucosa; Humans; Mice; Mice, Inbred C57BL; Protective Agents; Pyrazoles; Quinolones; Sulfonamides

2010
Augmented chondroprotective effect of coadministration of celecoxib and rebamipide in the monosodium iodoacetate rat model of osteoarthritis.
    Archives of pharmacal research, 2013, Volume: 36, Issue:1

    Topics: Administration, Oral; Alanine; Animals; Arthritis, Experimental; Behavior, Animal; Cartilage; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Injections, Intra-Articular; Iodoacetic Acid; Male; Osteoarthritis; Pain; Pyrazoles; Quinolones; Rats; Rats, Wistar; Sulfonamides

2013
Pharmacokinetic interactions between rebamipide and selected nonsteroidal anti-inflammatory drugs in rats.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2014, Mar-12, Volume: 53

    Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Celecoxib; Diclofenac; Drug Interactions; Male; Protein Binding; Pyrazoles; Quinolones; Rats; Rats, Sprague-Dawley; Sulfonamides

2014
Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats.
    European journal of pharmacology, 2013, Nov-15, Volume: 720, Issue:1-3

    Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Celecoxib; Cell Adhesion Molecules; Creatinine; Diclofenac; Dinoprostone; Drug Interactions; Kidney; Kidney Diseases; Male; Nitric Oxide; Potassium; Pyrazoles; Quinolones; Rats; Rats, Sprague-Dawley; Sodium; Sulfonamides

2013
A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors.
    International journal of oncology, 2014, Volume: 44, Issue:6

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Atorvastatin; Celecoxib; Cell Line, Tumor; Cell Proliferation; Female; Heptanoic Acids; Humans; Injections, Intraperitoneal; Mice; Mice, SCID; Neoplasms, Experimental; Pancreatic Neoplasms; Pyrazoles; Pyrroles; Quinolones; Sulfonamides; Xenograft Model Antitumor Assays

2014
Mcl-1 is an important therapeutic target for oral squamous cell carcinomas.
    Oncotarget, 2015, Jun-30, Volume: 6, Issue:18

    Topics: 4-Nitroquinoline-1-oxide; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy-Related Protein 5; Autophagy-Related Protein 7; bcl-X Protein; Beclin-1; Biphenyl Compounds; Carcinoma, Squamous Cell; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Female; Gossypol; Humans; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; Mitophagy; Mouth Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Nitrophenols; Piperazines; Proto-Oncogene Proteins; Quinolones; Random Allocation; RNA Interference; RNA, Small Interfering; Sulfonamides; Ubiquitin-Activating Enzymes; Xenograft Model Antitumor Assays

2015
Celecoxib or diclofenac hepatic status in the presence or absence of rebamipide.
    European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:17

    Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Male; Quinolones; Rats; Rats, Sprague-Dawley

2015
Cooperative effect of BI-69A11 and celecoxib enhances radiosensitization by modulating DNA damage repair in colon carcinoma.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:5

    Topics: Apoptosis; Benzimidazoles; Carcinoma; Celecoxib; Colonic Neoplasms; Combined Modality Therapy; DNA Breaks, Double-Stranded; DNA Damage; DNA Repair; HCT116 Cells; Humans; Quinolones; Radiation Tolerance; Radiation-Sensitizing Agents; Radiation, Ionizing; Signal Transduction

2016
Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cancer sphere-forming cells.
    European journal of pharmacology, 2021, Feb-15, Volume: 893

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Atorvastatin; Celecoxib; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Neoplastic Stem Cells; Pancreatic Neoplasms; Quinolones; Signal Transduction; Spheroids, Cellular

2021